A $150-billion U.S. merger between Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) has been called off after the Obama administration issued new rules designed to crack down on corporate tax avoidance.
The pharmaceutical link-up was designed to allow New York-based Pfizer to move its corporate headquarters to Ireland, and possibly reduce its tax bill. … … View the full article at: Pfizer-Allergan Merger Scrapped